Clinical trials: sponsored by Fox Chase Cancer Center
Diabetes Mellitus, Type 2
A Biobehavioral Model of Diabetes Risk in Chinese Immigrants
This prospective, longitudinal study of Chinese American immigrants will examine whether psychosocial factors (e.g., acculturative stress, social isolation, discrimination) are associated with markers of type 2 diabetes risk over…
- Trial name
- NCT02449213
- Where
- United States
- Volunteers
- 650 people, healthy volunteers welcome
- Sponsor
- Fox Chase Cancer Center
Acute Myeloid Leukemia, Myelodysplastic Syndrome
Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDS
The purpose of this study is to find a new way to treat Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML).
- Conditions
- Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia
- Trial name
- NCT02190695
- Testing
- Decitabine, Carboplatin, Arsenic trioxide
- Where
- 2 sites in United States
- Volunteers
- 92 people
- Sponsor
- Fox Chase Cancer Center
Colorectal Adenocarcinoma
Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma
Establish the tolerability and safety of aimed dose of both quinacrine and capecitabine in combination to treat patients with advanced colorectal adenocarcinoma.
- Trial name
- NCT01844076
- Testing
- Quinacrine and Capecitabine
- Where
- United States
- Volunteers
- 19 people
- Sponsor
- Fox Chase Cancer Center
Cancer of the Head and Neck
A Web-Based Multimedia Intervention for Head and Neck Cancer Patients
The overall goal is to develop and examine the acceptability of a web-based (Internet) intervention program for patients with head and neck cancer who have recently completed radiation therapy.
- Trial name
- NCT02442336
- Testing
- My Journey AHead
- Where
- United States
- Volunteers
- 80 people
- Sponsor
- Fox Chase Cancer Center
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Safety and Activity of Digoxin With Decitabine in Adult AML and MDS
The primary hypothesis is that digoxin can be safely added to decitabine and will increase the response rates in medically unfit patients with newly diagnosed AML/MDS or those with relapsed/refractory AML/MDS.
- Trial name
- NCT03113071
- Testing
- Decitabine, Digoxin
- Where
- 2 sites in United States
- Volunteers
- 1 people
- Sponsor
- Fox Chase Cancer Center
Breast Cancer Female
Addressing Sexual Concerns in Breast Cancer: Patient Intervention Study
The goal of this study is to evaluate an educational video intervention (called Starting the Conversation) aimed to enhance breast cancer patients' beliefs about and communication with respect to sexual concerns.
- Trial name
- NCT03624972
- Testing
- Starting the Conversation Video, Sexual and Menopausal Health Resources
- Where
- United States
- Volunteers
- 153 people
- Sponsor
- Fox Chase Cancer Center
Metastatic Colorectal Cancer
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
RATIONALE: Drugs used in chemotherapy, such as fluorouracil, leucovorin calcium, oxaliplatin, capecitabine, and irinotecan hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells or by…
- Trial name
- NCT01280643
- Testing
- fluorouracil, leucovorin calcium, oxaliplatin
- Where
- United States
- Volunteers
- 3 people
- Sponsor
- Fox Chase Cancer Center
Laryngeal Neoplasms
Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function
The aim of this study is to define a new treatment technique for T1a larynx cancer that maintains excellent local control with less extensive radiation fields.
- Trial name
- NCT02633540
- Testing
- IMRT Radiation
- Where
- United States
- Volunteers
- 2 people
- Sponsor
- Fox Chase Cancer Center
Neuroendocrine Tumors
A Study of Pembrolizumab in Patients With Neuroendocrine Tumors
The purpose of this research study is to test if pembrolizumab is safe and effective for treating patients with metastatic high-grade neuroendocrine tumors who have failed platinum based chemotherapy.The study drug, pembrolizumab…
- Trial name
- NCT02939651
- Testing
- Pembrolizumab
- Where
- 2 sites in United States
- Volunteers
- 21 people
- Sponsor
- Fox Chase Cancer Center
Pancreatic Cancer
Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.
- Trial name
- NCT00066677
- Testing
- rhuMAB-VEGF, docetaxel
- Where
- United States
- Volunteers
- 32 people
- Sponsor
- Fox Chase Cancer Center
Prostate Cancer, Sexual Dysfunction
Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Intensity-modulated radiation therapy (radiation directed at the tumor more precisely than in standard radiation therapy) may reduce damage to healthy…
- Conditions
- Prostate Cancer, Sexual Dysfunction, Sexuality and Reproductive Issues
- Trial name
- NCT00084552
- Testing
- radiation therapy
- Where
- United States
- Volunteers
- 116 people
- Sponsor
- Fox Chase Cancer Center
Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific
Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma
This phase I trial is studying the side effects and best dose of giving ridaforolimus and vorinostat together in treating patients with advanced solid tumors or lymphoma.
- Trial name
- NCT01169532
- Testing
- ridaforolimus, vorinostat, biopsy
- Where
- United States
- Volunteers
- 16 people
- Sponsor
- Fox Chase Cancer Center
Malignant Neoplasm
Next Generation Sequence Target-Directed Therapy in Treating Patients With Cancer
This randomized clinical trial studies how well next generation sequence target-directed therapy works in treating patients with cancer. Next generation sequencing is a test that screens for mutations to cancer related genes.
- Trial name
- NCT02132845
- Testing
- cytology specimen collection procedure, targeted therapy, therapeutic procedure
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Fox Chase Cancer Center
Rectal Cancer, Low Anterior Resection
Feasibility Bowel Dysfunction Program After Low Anterior Resection
This study will facilitate a better understanding of the overall experience of our rectal cancer survivors after Low Anterior Resection for rectal cancer.
- Trial name
- NCT04733794
- Testing
- Stoma reversal
- Where
- United States
- Volunteers
- 14 people
- Sponsor
- Fox Chase Cancer Center
Conflict, Decisional Conflict
Mychoice: Testing an Interactive mHealth Tool
Investigators aim to test a culturally diverse and patient guided mHealth decision tool called mychoice, which allows patients to explore their concerns and questions related to clinical trial participation, as well as create a…
- Trial name
- NCT03427177
- Testing
- mychoice
- Where
- 5 sites in United States
- Volunteers
- 257 people
- Sponsor
- Fox Chase Cancer Center
Cervical Carcinoma
Cervical Cancer Screening Intervention Among Korean American Women
This is a randomized trial to evaluate the effects of a community-based intervention on increasing cervical cancer screening rates in underserved Korean American women.
- Trial name
- NCT02594826
- Testing
- Culturally appropriate intervention, General health education control
- Where
- United States
- Volunteers
- 744 people, healthy volunteers welcome
- Sponsor
- Fox Chase Cancer Center
BRCA1 Mutation, Breast Cancer
Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of recombinant human chorionic gonadotropin may prevent breast cancer in premenopausal women with BRCA1 mutations.
- Trial name
- NCT00700778
- Testing
- recombinant human chorionic gonadotropin, microarray analysis, immunohistochemistry staining method
- Where
- 3 sites in United States, Austria
- Volunteers
- 2 people
- Sponsor
- Fox Chase Cancer Center
Cancer of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction
A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery
The purpose of the study is to determine the most tolerable and safe dose of ZD6474 (Zactima, Vandetanib) when given with standard chemotherapy, radiation therapy and surgery in patients with cancer of the esophagus
- Conditions
- Cancer of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Cancer of the Stomach
- Trial name
- NCT01183559
- Testing
- Vandetanib, 5 Fluorouracil (FU), Carboplatin
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- Fox Chase Cancer Center
Anaplastic Large Cell Lymphoma, ALK-Positive
Brigatinib in Relapsed or Refractory ALK-Positive Anaplastic Large Cell Lymphoma
FDA approved drugs to treat patients with relapsed or refractory anaplastic large cell lymphoma (ALCL) has a median progression free survival of 20 months. Majority of patients relapse in 2 years.
- Trial name
- NCT03719898
- Testing
- Brigatinib
- Where
- United States
- Sponsor
- Fox Chase Cancer Center
Cancer of Pancreas
A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients
Despite evidence regarding the benefits of physical activity in various cancer patient populations, the effects of a home-based walking program for pancreatic cancer patients have been under-explored.
- Trial name
- NCT02442323
- Testing
- Walking Intervention
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- Fox Chase Cancer Center